Evidence map›Paper›PMID 37210406›Full record

ArticleCellular and molecular life sciences : CMLS2023

Phosphorylation of STAT3 at Tyr705 contributes to TFEB-mediated autophagy-lysosomal pathway dysfunction and leads to ischemic injury in rats.

Yueyang Liu, Xiaohang Che, Xiangnan Yu, Hanxiao Shang, Peirui Cui, Xiaoxiao Fu, Xianda Lu, Yuhuan Liu, Chunfu Wu, Jingyu Yang

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yueyang LiuDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Xiaohang CheDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Xiangnan YuDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Hanxiao ShangDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Peirui CuiDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Xiaoxiao FuDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Xianda LuDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Yuhuan LiuDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Chunfu WuDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Jingyu YangDepartment of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China. yangjingyu2006@gmail.com.ORCID http://orcid.org/0000-0002-2791-5281
Shenyang Pharmaceutical University · CN

Funding

National Natural Science Foundation of China 82074056
6 · The paper itself

Abstract

We previously reported that permanent ischemia induces marked dysfunction of the autophagy-lysosomal pathway (ALP) in rats, which is possibly mediated by the transcription factor EB (TFEB). However, it is still unclear whether signal transducer and activator of transcription 3 (STAT3) is responsible for the TFEB-mediated dysfunction of ALP in ischemic stroke. In the present study, we used AAV-mediated genetic knockdown and pharmacological blockade of p-STAT3 to investigate the role of p-STAT3 in regulating TFEB-mediated ALP dysfunction in rats subjected to permanent middle cerebral occlusion (pMCAO). The results showed that the level of p-STAT3 (Tyr705) in the rat cortex increased at 24 h after pMCAO and subsequently led to lysosomal membrane permeabilization (LMP) and ALP dysfunction. These effects can be alleviated by inhibitors of p-STAT3 (Tyr705) or by STAT3 knockdown. Additionally, STAT3 knockdown significantly increased the nuclear translocation of TFEB and the transcription of TFEB-targeted genes. Notably, TFEB knockdown markedly reversed STAT3 knockdown-mediated improvement in ALP function after pMCAO. This is the first study to show that the contribution of p-STAT3 (Tyr705) to ALP dysfunction may be partly associated with its inhibitory effect on TFEB transcriptional activity, which further leads to ischemic injury in rats.

Indexed as

AutophagySTAT3 Transcription FactorAnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsIschemiaLysosomesPhosphorylationRatsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsStat3 protein, ratSTAT3 Transcription FactorTFEB protein, ratAutophagy-lysosomal pathwayIschemic strokeLysosomal membrane permeabilizationSignal transducer and activator of transcription 3Transcription factor EB

Identifiers

PMID37210406
PMCPMC11072684
OpenAlexW4377121551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.